Le Lézard
Classified in: Health
Subject: CCA

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024


ALAMEDA, Calif., July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after market close on Tuesday, July 30, 2024 at 4:30 PM Eastern Time. A press release with second quarter 2024 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations
Penumbra, Inc.
[email protected]
Source: Penumbra, Inc.

SOURCE Penumbra, Inc.


These press releases may also interest you

at 18:05
Teva Pharmaceutical Industries Ltd. announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live...

at 18:05
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that it has closed a non-brokered private placement,...

at 18:00
Global technology2use company CHG-MERIDIAN continues its strong growth path in Australia and New Zealand (ANZ) with the acquisition of Maia Financial Pty Limited's (Maia Financial) asset portfolio on June...

at 17:45
The global load monitoring systems market size is estimated to grow by USD 820.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 4.34% during the forecast period. Increasing use of load monitoring...

at 17:31
DelveInsight's PD-(L)1 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging PD-(L)1...

at 17:30
Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on July 1, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock...



News published on and distributed by: